Skip to main content
Clinical Trials/CTRI/2023/02/049773
CTRI/2023/02/049773
Recruiting
Phase 2

A prospective study to assess the feasibility of stereotactic body radiation therapy (SBRT) in lymph nodal oligometastatic disease (LN-SBRT) - LN-SBRT

PGIMER CHANDIGARH0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C00-D49- Neoplasms
Sponsor
PGIMER CHANDIGARH
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Lymph node oligometastatic disease in the neck, mediastinum, retroperitoneum, or pelvis
  • 2\) All primary tumors of colorectal, gastric, esophagus, lung, breast, gynaecological cancers or any other site
  • 3\) KPS \= 70
  • 4\) Age \> 18 years

Exclusion Criteria

  • More than 5 metastases
  • 2\) KPS \= 60
  • 3\) Pre\-existing collagen vascular disease
  • 4\) Age \< 18 years
  • 5\) Pregnant and Lactating women
  • 6\) Disseminated disease

Outcomes

Primary Outcomes

Not specified

Similar Trials